SCNI
Scinai Immunotherapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.72
−3.80%Oct 14, 2026, 12:00 UTC
Scinai Immunotherapeutics entered into a securities purchase agreement with an existing institutional investor to sell 2,458,334 ADSs or pre-funded warrants, together with Series A-1 warrants to purchase up to 3,687,501 ADSs.
Source:Sep 21, 2026, 11:00 UTC
Scinai Immunotherapeutics regained compliance with Nasdaq Listing Rule 5550(a)(2) after 19 consecutive business days with a closing bid price at or above $1.00, closing the minimum bid price matter.
Jun 10, 2026, 11:55 UTC
Scinai Immunotherapeutics Ltd reported financial results for the first quarter of 2026.